Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Margaret H Collins"'
Autor:
Mirna Chehade, MD, MPH, Benjamin L. Wright, MD, Samantha Walsh, MLS, MA, Dominique D. Bailey, MD, Amanda B. Muir, MD, Amy D. Klion, MD, Margaret H. Collins, MD, Carla M. Davis, MD, Glenn T. Furuta, MD, Sandeep Gupta, MD, Paneez Khoury, MD, Kathryn A. Peterson, MD, Elizabeth T. Jensen, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100260- (2024)
Background: The demographic characteristics of patients with eosinophilic gastrointestinal diseases (EGIDs) are poorly understood. Population-based assessments of EGID demographics may indicate health disparities in diagnosis. Objectives: We aimed to
Externí odkaz:
https://doaj.org/article/1b5978b1272b4a1e8c778c55c02c4eb6
Autor:
Alok K. Verma, Murli Manohar, Sathisha Upparahalli Venkateshaiah, Uwe Blecker, Margaret H. Collins, Anil Mishra
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 5, Iss 1, Pp 99-100.e7 (2018)
Externí odkaz:
https://doaj.org/article/546898d8f032460793a4617fa045c791
Autor:
Evan S, Dellon, Paneez, Khoury, Amanda B, Muir, Chris A, Liacouras, Ekaterina, Safroneeva, Dan, Atkins, Margaret H, Collins, Nirmala, Gonsalves, Gary W, Falk, Jonathan M, Spergel, Ikuo, Hirano, Mirna, Chehade, Alain M, Schoepfer, Calies, Menard-Katcher, David A, Katzka, Peter A, Bonis, Albert J, Bredenoord, Bob, Geng, Elizabeth T, Jensen, Robert D, Pesek, Paul, Feuerstadt, Sandeep K, Gupta, Alfredo J, Lucendo, Robert M, Genta, Girish, Hiremath, Emily C, McGowan, Fouad J, Moawad, Kathryn A, Peterson, Marc E, Rothenberg, Alex, Straumann, Glenn T, Furuta, Seema S, Aceves
Publikováno v:
J Allergy Clin Immunol
BACKGROUND & AIMS Disease activity and severity of eosinophilic esophagitis (EoE) dictate therapeutic options and management, but the decision-making process for determining severity varies among practitioners. To reduce variability in practice patte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109badf6bda27e0269585b1c7ea9cd04
Autor:
Kathryn A. Peterson, Gary W. Falk, Neil Stahl, Yehudith Assouline-Dayan, Ikuo Hirano, Margaret H. Collins, George D. Yancopoulos, Neil M.H. Graham, Jennifer D. Hamilton, Allen Radin, Evan S. Dellon, Marc E. Rothenberg, Qiong Zhao, Mirna Chehade, Bolanle Akinlade, Zhen Chen, Brian N. Swanson, Gianluca Pirozzi, Alain M. Schoepfer, Leda Mannent, Ekaterina Safroneeva
Publikováno v:
Hirano, Ikuo; Dellon, Evan S; Hamilton, Jennifer D; Collins, Margaret H; Peterson, Kathryn; Chehade, Mirna; Schoepfer, Alain M; Safroneeva, Ekaterina; Rothenberg, Marc E; Falk, Gary W; Assouline-Dayan, Yehudith; Zhao, Qiong; Chen, Zhen; Swanson, Brian N; Pirozzi, Gianluca; Mannent, Leda; Graham, Neil M H; Akinlade, Bolanle; Stahl, Neil; Yancopoulos, George D; ... (2020). Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology, 158(1), pp. 111-122. Elsevier 10.1053/j.gastro.2019.09.042
BACKGROUND & AIMS Eosinophilic esophagitis (EoE) is an allergen-mediated inflammatory disease with no approved treatment in the United States. Dupilumab, a VelocImmune-derived human monoclonal antibody against the interleukin 4 (IL4) receptor, inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e64ac1a750f5e3f39a916ac979753e
https://boris.unibe.ch/133886/8/1-s2.0-S0016508519414157-main.pdf
https://boris.unibe.ch/133886/8/1-s2.0-S0016508519414157-main.pdf